ACERUS Beneish M Score

ASPCF -  USA Stock  

USD 0.03  0.0018  6.38%

This module uses fundamental data of ACERUS PHARMACEUTICALS to approximate the value of its Beneish M Score. ACERUS PHARMACEUTICALS M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Please continue to ACERUS PHARMACEUTICALS Piotroski F Score and ACERUS PHARMACEUTICALS Altman Z Score analysis.

ACERUS Beneish M Score 

 
Refresh
At this time, ACERUS PHARMACEUTICALS's M Score is unavailable. The earnings manipulation may begin if ACERUS PHARMACEUTICALS's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by ACERUS PHARMACEUTICALS executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of ACERUS PHARMACEUTICALS's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-4.84
Beneish M Score - Unavailable
Elasticity of Receivables
N/A
Asset Quality
N/A
Expense Coverage
N/A
Gross Margin Strengs
N/A
Accruals Factor
N/A
Depreciation Resistance
N/A
Net Sales Growth
N/A
Financial Leverage Condition
N/A

About ACERUS PHARMACEUTICALS Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

About ACERUS PHARMACEUTICALS Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ACERUS PHARMACEUTICALS CORP's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ACERUS PHARMACEUTICALS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ACERUS PHARMACEUTICALS CORP based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for mens and womens health. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada. ACERUS PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 10 people.

ACERUS PHARMACEUTICALS Investors Sentiment

The influence of ACERUS PHARMACEUTICALS's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in ACERUS. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - ASPCF

ACERUS PHARMACEUTICALS Investor Sentiment

Macroaxis portfolio users are unresponsive in their sentiment towards investing in ACERUS PHARMACEUTICALS CORP. What is your sentiment towards investing in ACERUS PHARMACEUTICALS CORP? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Pair Trading with ACERUS PHARMACEUTICALS

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ACERUS PHARMACEUTICALS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACERUS PHARMACEUTICALS will appreciate offsetting losses from the drop in the long position's value.

ACERUS PHARMACEUTICALS Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for ACERUS PHARMACEUTICALS and Catalent. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Please continue to ACERUS PHARMACEUTICALS Piotroski F Score and ACERUS PHARMACEUTICALS Altman Z Score analysis. Note that the ACERUS PHARMACEUTICALS information on this page should be used as a complementary analysis to other ACERUS PHARMACEUTICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for ACERUS OTC Stock analysis

When running ACERUS PHARMACEUTICALS price analysis, check to measure ACERUS PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACERUS PHARMACEUTICALS is operating at the current time. Most of ACERUS PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of ACERUS PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ACERUS PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of ACERUS PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
The market value of ACERUS PHARMACEUTICALS is measured differently than its book value, which is the value of ACERUS that is recorded on the company's balance sheet. Investors also form their own opinion of ACERUS PHARMACEUTICALS's value that differs from its market value or its book value, called intrinsic value, which is ACERUS PHARMACEUTICALS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACERUS PHARMACEUTICALS's market value can be influenced by many factors that don't directly affect ACERUS PHARMACEUTICALS underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACERUS PHARMACEUTICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine ACERUS PHARMACEUTICALS value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACERUS PHARMACEUTICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.